Abata Therapeutics

Senior/ Staff Research Engineer

London, England, United Kingdom

Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Pharmaceuticals, Artificial Intelligence, Drug DiscoveryIndustries

Requirements

Candidates must possess a Bachelor's degree in Computer Science, Engineering, or a related field, coupled with over 7 years of industry experience in AI, machine learning, or similar roles, demonstrating a history of successfully implementing and deploying AI models in production. Proficiency in Python and C++, deep expertise in frameworks like PyTorch/Jax, a strong grasp of deep learning fundamentals including neural network architectures, optimization techniques, and evaluation metrics, and experience with distributed training and inference of large-scale AI models on thousands of GPUs using DDP, FSDP, etc., are essential. Experience with performance optimization of large-scale AI models, effective communication and collaboration skills for fast-paced, multidisciplinary team environments, and experience in solving complex problems by comparing alternative solutions, tradeoffs, and diverse viewpoints are also required. Preferred qualifications include a publication track record at top AI conferences, experience working cross-functionally, familiarity with different GPU architectures, cloud environments, low-level hardware optimization, and custom CUDA kernels, as well as contributions to open-source projects.

Responsibilities

The Senior/Staff Research Engineer will drive the development of state-of-the-art AI models for drug discovery tasks, utilizing deep learning frameworks and scaling distributed training of large AI models on GPUs. Responsibilities include profiling and optimizing AI models for both training and inference, staying current with AI and machine learning advancements to identify innovation opportunities, and contributing to technical documentation, reports, and presentations. This role also entails providing deep technical leadership in the development and optimization of core AI models that power the company's drug discovery initiatives.

Skills

AI
Machine Learning
Deep Learning
Generative AI
Drug Discovery
Distributed Training
GPU
Model Optimization
Technical Documentation
Research

Abata Therapeutics

Develops therapies for autoimmune diseases

About Abata Therapeutics

Abata Therapeutics develops therapies for autoimmune diseases, focusing on type 1 diabetes. Their main product, ABA 201, is a Treg cell therapy aimed at patients with some remaining beta cell function. This therapy works by utilizing regulatory T cells to improve patient outcomes. Unlike many competitors, Abata targets a specific niche within the autoimmune disease market and collaborates with partners like ElevateBio for process development and manufacturing. The company's goal is to transform treatment options for autoimmune diseases through advanced research and development.

Cambridge, MassachusettsHeadquarters
2021Year Founded
$184.8MTotal Funding
EARLY_VCCompany Stage
BiotechnologyIndustries
11-50Employees

Risks

Intensifying competition from companies like Sangamo Therapeutics may impact Abata's market share.
Stringent FDA scrutiny on manufacturing could delay Abata's clinical trials.
Rising clinical trial costs pose financial risks to Abata's pipeline progression.

Differentiation

Abata focuses on Treg cell therapies for autoimmune diseases like MS and diabetes.
Their lead product, ABA 201, targets type 1 diabetes with remaining beta cell function.
Abata's strategic partnership with ElevateBio enhances their manufacturing capabilities.

Upsides

Recent investment from Bristol Myers Squibb boosts Abata's Treg therapy pipeline development.
FDA's accelerated approval pathways may expedite Abata's clinical trials.
Growing autoimmune disease prevalence increases demand for Abata's innovative treatments.

Land your dream remote job 3x faster with AI